Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028025 · ClinicalTrials.gov registry record · NA
Comparing TR Band to Statseal in Conjunction With TR Band
A NA study of Cardiovascular Diseases and Coronary Artery Disease, sponsored by VA Long Beach Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 184
- Enrollment target
- 1
- Study location
NCT03028025: Completed NA study of Cardiovascular Diseases and Coronary Artery Disease, sponsored by VA Long Beach Healthcare System.
NCT03028025 is a NA study of Cardiovascular Diseases and Coronary Artery Disease that has completed, run by VA Long Beach Healthcare System. The registered enrollment target is 184 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03028025, a NA study of Cardiovascular Diseases and Coronary Artery Disease, has completed, sponsored by VA Long Beach Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objectives of this study are to evaluate the performance of StatSeal Advanced used in conjunction with the TR Band (SSA) as compared to the TR Band without SSA (TRB) relative to: the incidence of peri-procedural radial artery occlusion (RAO) at discharge or 24 hours, whichever occurs first, and the Time to Hemostasis (TTH).
Primary Outcome
Time to deflation for removal of the TR Band (or TR Band and Statseal) for each group was measured in minutes.
Conditions Studied
Interventions
- DEVICE StatSeal
- DEVICE TR Band
Study Locations (1)
California
- Veteran Affairs Long Beach - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2017-08-01 |
| Phase | NA |
What the finished NCT03028025 record still lists
NCT03028025 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower).
The record links to 7 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which StatSeal is the first listed.
NCT03028025 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03028025 about?
NCT03028025 is a clinical study titled "Comparing TR Band to Statseal in Conjunction With TR Band". The primary objectives of this study are to evaluate the performance of StatSeal Advanced used in conjunction with the TR Band (SSA) as compared to the TR Band without SSA (TRB) relative to: the incidence of peri-procedural radial artery occlusion (RAO) at discharge or 24 hours, whichever occurs fir...
What is the current status of trial NCT03028025?
This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2017-01-01. Estimated completion is 2017-08-01.
What conditions does trial NCT03028025 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Coronary Artery Disease, Atherosclerosis, Angina Pectoris, Arterial Occlusion.
What interventions are being tested in trial NCT03028025?
The interventions under investigation include: StatSeal (DEVICE), TR Band (DEVICE).
Who is sponsoring clinical trial NCT03028025?
This trial is sponsored by VA Long Beach Healthcare System, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03028025 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03028025's enrollment target sits among peer trials
184 158th of 300 higher than 143 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI